Redundant and dangerous health research – how can you support better research practice? 8 November 2016, Bergen, Norway

Welcome to the seminar “Redundant and dangerous health research – how can you support better research practices?”

The seminar is organised in collaboration with the Centre for Evidence-Based Practice and is a follow-up to the seminar about evidence-based research and redundant health research in Norway that the Centre and the EBRNetwork arranged in December 2014.

When conducting evidence-based research the research questions are based on systematic reviews of previous research and the results are put into context with earlier research.

Scientists often assume that if they refer to well-known sources when they prepare new research and interpret results, they fulfill the expectation that they work evidence-based. A number of studies clearly shows, however, that many researchers are selective and uncritical in their use of individual studies if they do not conduct a systematic review of the literature. This can result in patients participating in unnecessary, and potentially dangerous, research projects.

We invite you to a seminar with interesting presentations and discussions where patients are the primary focus!


CHAIR: Hans Lund

09:30 – 10:00 Coffee

10:00 – 10.05 Welcome

10:05 – 10:20 The scientific process involves a systematic approach at each step to avoid bias – but the awareness about current knowledge is not based upon a systematic /scientific approach
Dr. Hans Lund, Associate Professor, University of Southern Denmark and Professor, Bergen University College

10:20 – 10:35 Do researchers demonstrate knowledge about all earlier studies within their area?
Dr. Caroline Blaine, Clinical Editor, BMJ

10:35 – 10:55 Do researchers conduct redundant health research?
Dr. Malcolm Macleod, Professor, University of Edinburgh

10:55 – 11:10 How do researchers cite earlier research?
Dr. Jennifer Yost, Assistant Professor, McMaster University

11:10 – 11:30 Presentation of the EBRNetwork – invitation to participate
Dr. Hans Lund, Associate Professor, University of Southern Denmark, Professor, Bergen University College

11:30 – 12:30 Lunch

12:30 – 12:45 Evidence-based research – what does it mean for consumers?
Peg Ford, Co-founder, President, Ovarian Cancer Alliance of San Diego & Hanna Nykvist, Associate Professor, Bergen University College

12:45 – 13:30 Response from consumers to the challenges presented in the first session
Tone Hansen, Chairperson, Leukaemia Association & Claus Ingebrigtsen, Lecturer, Hordaland County Council

13:30 – 14:30 Panel Discussion
Consumers & the EBRNetwork Steering Group